ADMA BIOLOGICS INC

ADMA05 Dec 2024
Healthcare
$19.84
-0.01 (-0.75%)
Lowest Today
$19.61
Highest Today
$19.98
Today’s Open
$19.84
Prev. Close
$19.92
52 Week High
$23.64
52 Week Low
$3.6
To Invest in ADMA BIOLOGICS INC

ADMA BIOLOGICS INC

Healthcare
ADMA05 Dec 2024
-0.01 (-0.75%)
1M
3M
6M
1Y
5Y
Low
$19.61
Day’s Range
High
$19.98
19.61
52 Week Low
$3.6
52-Week Range
52 Week High
$23.64
3.6
1 Day
-
1 Week
-8.75%
1 month return
+3.96%
3 month return
+18.05%
6 month return
+96.93%
1 Year return
+413.8%
3 Years return
+1449.41%
5 Years return
+370.12%
10 Years return
-
Institutional Holdings
BlackRock Inc
7.89
Vanguard Group Inc
7.66
iShares Core S&P Small-Cap ETF
6.38
State Street Corp
5.5
Amvescap Plc.
5.34
Morgan Stanley - Brokerage Accounts
3.64
Vanguard Total Stock Mkt Idx Inv
3.01

Market Status

Fundamentals
Market Cap
5052.63 mln
PB Ratio
20.5
PE Ratio
72.93
Enterprise Value
4778.48 mln
Total Assets
329.18 mln
Volume

Company Financials

Fund house & investment objective

Company Information
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
Organisation
ADMA BIOLOGICS INC
Employees
624
Industry
Biotechnology
CEO
Mr. Adam S. Grossman
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step